Treatment Approach for Synchronous Colon Cancer

Resectability Assessment and Treatment Algorithm

For patients with synchronous colon cancer and resectable metastases, the American Society of Clinical Oncology recommends administering 3 months of preoperative FOLFOX chemotherapy, followed by surgical resection of both the primary tumor and metastases, then completing 3 additional months of postoperative FOLFOX for a total of 6 months perioperative treatment 1, 2, 3
Patients with a single small (<2 cm) liver metastasis may proceed directly to upfront surgery of both primary and metastatic lesions, as these small lesions may disappear during chemotherapy and become undetectable intraoperatively 1, 5, 3
Following upfront surgery without preoperative chemotherapy, administer 6 months of postoperative FOLFOX 1, 3

For bleeding or perforation, perform primary lesion resection, followed by systemic therapy 6
For obstruction, achieve local relief first (e.g., colon stent placement, colostomy, or primary resection), then initiate systemic therapy 6
Prophylactic resection of asymptomatic primary tumors in unresectable metastatic disease is NOT recommended 4

The standard FOLFOX regimen consists of oxaliplatin, leucovorin, and fluorouracil, administered every 2 weeks 1, 2, 5, 3
Perioperative approach: 3 months preoperatively + 3 months postoperatively = 6 months total 1, 2, 5, 3

Complete radiographic response to chemotherapy is prognostically favorable but should be avoided to enable surgical resection 1, 3
Progression during preoperative chemotherapy indicates aggressive tumor biology and predicts worse outcomes even with resection 1, 3
Patients who failed within 12 months of previous adjuvant oxaliplatin should NOT receive perioperative FOLFOX 1, 2, 5